NS
Neelam Suri
About Neelam Suri
Data last updated:
Neelam Suri is a Director at Clyde Pharmaceutical Private Limited (since 2014). The company operates in Pharma. Clyde Pharmaceutical Private Limited reported revenue of ₹2.38 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Clyde Pharmaceutical Private Limited U47721UP2011PTC234959 | Director | 10 Mar 2014 | 2011 | ₹2.38 Cr (FY 2024) | Active |
Board colleagues of Neelam Suri
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kuldeep Kumar | 03365629 | Clyde Pharmaceutical Private Limited | Director |
| Purnima Adlakha | 03639684 | Clyde Pharmaceutical Private Limited | Director |
| Vishnu Dutta Agrawal | 05305095 | Clyde Pharmaceutical Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Neelam Suri
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neelam Suri
Neelam Suri currently holds 1 directorship: Clyde Pharmaceutical Private Limited (Director, since 10 Mar 2014, revenue ₹2.38 Cr (FY 2024)).
Neelam Suri was first appointed on 10 Mar 2014 as Director at Clyde Pharmaceutical Private Limited.
The current boards of Neelam Suri's companies include Kuldeep Kumar (Clyde Pharmaceutical Private Limited), Purnima Adlakha (Clyde Pharmaceutical Private Limited), Vishnu Dutta Agrawal (Clyde Pharmaceutical Private Limited).